X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse AJANTA PHARMA with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AJANTA PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-18
TEVA PHARMA
Dec-13
AJANTA PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,8182,848-   
Low Rs1,1062,474-   
Sales per share (Unadj.) Rs239.51,634.2-  
Earnings per share (Unadj.) Rs52.8102.1-  
Cash flow per share (Unadj.) Rs59.5234.2-  
Dividends per share (Unadj.) Rs089.37-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs230.01,815.3-  
Shares outstanding (eoy) m88.77848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.11.6 375.0%   
Avg P/E ratio x27.726.1 106.3%  
P/CF ratio (eoy) x24.611.4 216.3%  
Price / Book Value ratio x6.41.5 433.8%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m129,7822,256,172 5.8%   
No. of employees `0006.844.9 15.1%   
Total wages/salary Rs m3,7650-   
Avg. sales/employee Rs Th3,128.430,833.7 10.1%   
Avg. wages/employee Rs Th554.00-   
Avg. net profit/employee Rs Th689.71,926.2 35.8%   
INCOME DATA
Net Sales Rs m21,2581,385,821 1.5%  
Other income Rs m2420-   
Total revenues Rs m21,4991,385,821 1.6%   
Gross profit Rs m6,584379,508 1.7%  
Depreciation Rs m596112,017 0.5%   
Interest Rs m427,220 0.0%   
Profit before tax Rs m6,226240,271 2.6%   
Minority Interest Rs m01,092 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-157,725 0.0%   
Tax Rs m1,539-2,933 -52.5%   
Profit after tax Rs m4,68686,571 5.4%  
Gross profit margin %31.027.4 113.1%  
Effective tax rate %24.7-1.2 -2,024.9%   
Net profit margin %22.06.2 352.9%  
BALANCE SHEET DATA
Current assets Rs m12,236935,978 1.3%   
Current liabilities Rs m3,461816,252 0.4%   
Net working cap to sales %41.38.6 477.8%  
Current ratio x3.51.1 308.4%  
Inventory Days Days6091 66.3%  
Debtors Days Days8496 88.1%  
Net fixed assets Rs m11,140452,640 2.5%   
Share capital Rs m1773,411 5.2%   
"Free" reserves Rs m20,2370-   
Net worth Rs m20,4141,539,384 1.3%   
Long term debt Rs m10708,601 0.0%   
Total assets Rs m24,4863,167,045 0.8%  
Interest coverage x1,519.49.8 15,461.5%   
Debt to equity ratio x00.5 0.1%  
Sales to assets ratio x0.90.4 198.4%   
Return on assets %19.23.6 533.2%  
Return on equity %23.05.6 408.2%  
Return on capital %30.54.9 618.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,0520-   
CASH FLOW
From Operations Rs m2,854220,828 1.3%  
From Investments Rs m-2,604-78,248 3.3%  
From Financial Activity Rs m-2-264,898 0.0%  
Net Cashflow Rs m248-122,318 -0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 68.22 Rs / USD

Compare AJANTA PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare AJANTA PHARMA With: J.B.CHEMICALS  ELDER PHARMA  ALEMBIC PHARMA  GLENMARK PHARMA  NOVARTIS  



Today's Market

Sensex Opens Higher; Consumer Durables & Bank Stocks Lead(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.8% while the Hang Seng is down 0.4%.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jun 21, 2018 10:05 AM

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 8-QTR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS